You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
心通醫療-B(02160.HK)預計上半年虧損約6800萬元-7300萬元 同期虧損1.22億元
格隆匯 07-26 22:48

格隆匯7月26日丨心通醫療-B(02160.HK)公佈,集團預期於截至2021年6月30日止六個月錄得淨虧損(未經審核)約人民幣6800萬元至人民幣7300萬元,較截至2020年6月30日止六個月約人民幣1.22億元(未經審核)減少約40%至44%。

集團的預期淨虧損減少主要是由於(i)集團在VitaFlowTM商業化方面取得重大進展,令收入大幅增加;(ii)收入增加及生產成本有效控制帶來的毛利大幅提升;及(iii)融資成本及其他經營成本減少,此乃由於截至2020年6月30日止六個月的若干項目屬一次性及非經常性費用。截至2021年6月30日,中國已有超過200家醫院使用VitaFlowTM進行TAVI(經導管主動脈瓣植入術)手術,當中大部分為位於一線及二線城市的三甲醫院。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account